![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » SHANGHAI FIRM INVESTS IN GUANGDONG DRUG VENTURE
SHANGHAI FIRM INVESTS IN GUANGDONG DRUG VENTURE
October 24, 2005
SHANGHAI Industrial United Holding Co, Ltd plans to invest 105 million Hong Kong dollars (US$13.5 million) with several Guangzhou Province partners to set up a new pharmaceutical company in Guangdong Province, according to its statement to the Hong Kong Stock Exchange yesterday. Shanghai Industrial United will set up Guangzhou Tianpu Overseas Pharmaceuticals, acquiring a 58.10 percent stake worth 61 million yuan, along with Guangzhou Bopu Biotechnology Co, Guangdong Techpool Biochem Pharma Co and Guangzhou Venture Capital Limited.
Shanghai Daily (http://www.shanghaidaily.com/art/2005/10/22/206565/Shanghai_firm_invests_in_Guangdong_drug_venture.htm)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct